APC c.2831A>C ;(p.N944T)

Variant ID: 5-112174122-A-C

NM_000038.5(APC):c.2831A>C;(p.N944T)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.

Esmo Open
Cardone, Claudia C; Martinelli, Erika E; Troiani, Teresa T; Sforza, Vincenzo V; Avallone, Antonio A; Nappi, Anna A; Montesarchio, Vincenzo V; Andreozzi, Francesca F; Biglietto, Maria M; Calabrese, Filomena F; Bordonaro, Roberto R; Cordio, Stefano S; Bregni, Giacomo G; Febbraro, Antonio A; Garcia-Carbonero, Rocio R; Feliu, Jaime J; Cervantes, Andrés A; Ciardiello, Fortunato F
Publication Date: 2019

Variant appearance in text: APC: N944T
PubMed Link: 31555481
Variant Present in the following documents:
  • Main text
  • esmoopen-2019-000519.pdf
View BVdb publication page